Spyre Therapeutics, Inc. (SYRE) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2023 | $13.76 | +155.3% |
| 2022 | $-24.86 | +0.6% |
| 2021 | $-25.02 | -1546.1% |
| 2020 | $-1.52 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2023 | $13.76 | +155.3% |
| 2022 | $-24.86 | +0.6% |
| 2021 | $-25.02 | -1546.1% |
| 2020 | $-1.52 | — |